Martina Iovine
Overview
Explore the profile of Martina Iovine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quagliariello V, Canale M, Bisceglia I, Iovine M, Giordano V, Giacobbe I, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39457081
Cancer patients, especially long cancer survivors, are exposed to several cardio-metabolic diseases, including diabetes, heart failure, and atherosclerosis, which increase their risk of cardiovascular mortality. Therapy with glucagon-like peptide 1...
2.
Quagliariello V, Berretta M, Bisceglia I, Giacobbe I, Iovine M, Giordano V, et al.
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672567
Anthracycline-induced cardiomyopathies and sarcopenia are frequently seen in cancer patients, affecting their overall survival and quality of life; therefore, new cardioprotective and anti-sarcopenic strategies are needed. Vericiguat is a new...
3.
Quagliariello V, Bisceglia I, Berretta M, Iovine M, Canale M, Maurea C, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900189
Cancer patients treated with immune checkpoint inhibitors (ICIs) are exposed to a high risk of atherosclerosis and cardiometabolic diseases due to systemic inflammatory conditions and immune-related atheroma destabilization. Proprotein convertase...
4.
Quagliariello V, Berretta M, Buccolo S, Iovine M, Paccone A, Cavalcanti E, et al.
Front Oncol
. 2021 Jun;
11:680758.
PMID: 34178667
Renal cell carcinoma (RCC) represents the main renal tumors and are highly metastatic. Sunitinib, a recently-approved, multi-targeted Tyrosine Kinases Inhibitor (TKi), prolongs survival in patients with metastatic renal cell carcinoma...
5.
Quagliariello V, Bonelli A, Caronna A, Conforti G, Iovine M, Carbone A, et al.
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33182653
The coronavirus disease-2019 (COVID-19) is a highly transmissible viral illness caused by SARS-CoV-2, which has been defined by the World Health Organization as a pandemic, considering its remarkable transmission speed...
6.
Quagliariello V, Passariello M, Rea D, Barbieri A, Iovine M, Bonelli A, et al.
J Pers Med
. 2020 Oct;
10(4).
PMID: 33086484
Background: Several strategies based on immune checkpoint inhibitors (ICIs) have been developed for cancer therapy, opening to advantages in cancer outcomes. However, several ICI-induced side effects have emerged in these...